RxE2 Funding & Investors
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists, as trusted medication experts, to use their extensive patient insights and make clinical trials more accessible to patients, everywhere. This, in turn, vastly reduces clinical trial timelines and costs, helps patients achieve better health outcomes, and provides study sponsors with more accurate data.
rx-e2.comTotal Amount Raised: $3,543,346
RxE2 Funding Rounds
Series Unknown
$3,543,346
Funding info provided by Diffbot.